Angiotensin II induces endoplasmic reticulum stress in podocyte, which would be further augmented by PI3-kinase inhibition
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Introduction: Angiotensin II (Ang II) contributes to the pathological process of vascular structures, including renal glomeruli by hemodynamic and nonhemodynamic direct effects. On renal effects, Ang II plays an important role in the development of proteinuria and glomerulosclerosis by the modification of podocyte molecules and cell survival. In the present study, we investigated the effect of Ang II on endoplasmic reticulum (ER) stress in podocytes. Methods: We cultured mouse podocytes with increasing doses of Ang II and evaluated ER stress markers by Western blotting. Results: Ang II increased Bip protein, an ER chaperone, in a dose-dependent manner at 24 h, which was ameliorated by losartan, an angiotensin II type 1 receptor antagonist. Ang II also increased ER stress markers, such as phospho-PERK, phospho-eIF2α, and ATF4 proteins of podocyte, significantly in a dose-dependent manner at 24 h. Increased phospho-PERK and ATF4 proteins were further augmented by phosphoinositide 3 (PI3)-kinase inhibitor, LY294002, which suggested that Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4 axis via PI3-kinase pathway. Discussion: These studies suggest that Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4 axis via PI3-kinase pathway, which would contribute to the development of podocyte injury induced by Ang II, and the augmentation of PI3-kinase would be a therapeutic target.
Abstract
Introduction: Angiotensin II (Ang II) contributes to the pathological process of vascular structures, including renal glomeruli by hemodynamic and nonhemodynamic direct effects. On renal effects, Ang II plays an important role in the development of proteinuria and glomerulosclerosis by the modification of podocyte molecules and cell survival. In the present study, we investigated the effect of Ang II on endoplasmic reticulum (ER) stress in podocytes. Methods: We cultured mouse podocytes with increasing doses of Ang II and evaluated ER stress markers by Western blotting. Results: Ang II increased Bip protein, an ER chaperone, in a dose-dependent manner at 24 h, which was ameliorated by losartan, an angiotensin II type 1 receptor antagonist. Ang II also increased ER stress markers, such as phospho-PERK, phospho-eIF2α, and ATF4 proteins of podocyte, significantly in a dose-dependent manner at 24 h. Increased phospho-PERK and ATF4 proteins were further augmented by phosphoinositide 3 (PI3)-kinase inhibitor, LY294002, which suggested that Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4 axis via PI3-kinase pathway. Discussion: These studies suggest that Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4 axis via PI3-kinase pathway, which would contribute to the development of podocyte injury induced by Ang II, and the augmentation of PI3-kinase would be a therapeutic target.
참고문헌 (36)
- Timmermans PB., "Angiotensin II receptors and angiotensin II receptor antagonists", Pharmacol Rev, 45, pp.205~251 (1993)
- Kobori H., "The intrarenal renin-angiotensin system : from physiology to the pathobiology of hypertension and kidney disease", Pharmacol Rev, 59, pp.251~287 (2007)
- Aros C., "The renin-angiotensin system in progression, remission and regression of chronic nephropathies", J Hypertens., 20, pp.S45~S53 (2002)
- Remuzzi G., "Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes", J Clin Invest, 116, pp.288~296 (2006)
- Wolf G., "The role of angiotensin II in diabetic nephropathy : emphasis on nonhemodynamic mechanisms", Am J Kidney Dis, 29, pp.153~163 (1997)
- Siragy HM., "Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease", Am J Nephrol, 31, pp.541~550 (2010)
- Mundel P., "Structure and function of podocytes : an update", Anat Embryol(Berl), 192, pp.385~397 (1995)
- Asanuma K., "The role of podocytes in glomerular pathobiology", Clin Exp Nephrol, 7, pp.255~259 (2003)
- Ha TS., "Roles of adaptor proteins in podocyte biology", World J Nephrol, 2, pp.1~10 (2013)
- Xu C., "Endoplasmic reticulum stress : cell life and death decisions", J Clin Invest, 115, pp.2656~2664 (2005)
- Marciniak SJ., "CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum", Genes Dev, 18, pp.3066~3077 (2004)
- Kim R., "Role of the unfolded protein response in cell death", Apoptosis, 11, pp.5~13 (2006)
- Wang S., "The impact of the unfolded protein response on human disease", J Cell Biol, 197, pp.857~867 (2012)
- Inagi R., "Proteostasis in endoplasmic reticulum-new mechanisms in kidney disease", Nat Rev Nephrol, 10, pp.369~378 (2014)
- Mundel P., "Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines", Exp Cell Res, 236, pp.248~258 (1997)
- Bek MF., "Expression and function of C", EBP homology protein(GADD153)in podocytes, 2006, pp.168, 20~32
- Markan S., "Up regulation of the GRP-78 and GADD-153 and downregulation of Bcl-2proteins in primary glomerular diseases : a possible involvement of the ER stress pathway in glomerulonephritis", Mol Cell Biochem, 324, pp.131~138 (2009)
- Szegezdi E., "Mediators of endoplasmic reticulum stress-induced apoptosis", EMBO Rep, 7, pp.880~885 (2006)
- Lakshmanan AP., "Modulation of AT-1R", CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice, 2011, pp.44, 627~634
- Lindenmeyer MT., "Proteinuria and hyperglycemia induce endoplasmic reticulum stress", J Am Soc Nephrol, 19, pp.2225~2236 (2008)
- Sun HL., "ACE inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats", Exp Clin Endocrinol Diabetes, 117, pp.336~344 (2009)
- He F., "Regulation of CD2-associated protein influences podocyte endoplasmic reticulum stress-mediated apoptosis induced by albumin overload", Gene, 484, pp.18~25 (2011)
- Cybulsky AV., "Glomerular epithelial cell injury associated with mutant α-actinin-4", Am J Physiol Renal Physiol, 297, pp.F987~F995 (2009)
- Chen YM., "Laminin β2gene missense mutation produces endoplasmic reticulum stress in podocytes", J Am Soc Nephrol, 24, pp.1223~1233 (2013)
- Chiang CK., "Glomerular diseases : genetic causes and future therapeutics", Nat Rev Nephrol, 6, pp.539~554 (2010)
- Inagi R., "Involvement of endoplasmic reticulum(ER)stress in podocyte injury induced by excessive protein accumulation", Kidney Int, 68, pp.2639~2650 (2005)
- Chen S., "Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes", Cell Calcium, 50, pp.523~529 (2011)
- Liu G., "Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease", Biochem Biophys Res Commun, 370, pp.651~656 (2008)
- Morse E., "TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1", Am J Physiol Renal Physiol., 299, pp.F965~F972 (2010)
- Inoki K., "mTORC1activation in podocytes is a critical step in the development of diabetic nephropathy in mice", J Clin Invest, 121, pp.2181~2196 (2011)
- Ito N., "mTORC1activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome", Lab Invest, 91, pp.1584~1595 (2011)
- Welsh GI., "The podocyte cytoskeleton-key to a functioning glomerulus in health and disease", Nat Rev Nephrol, 8, pp.14~21 (2011)
- Huber TB., "Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling", Mol Cell Biol, 23, pp.4917~4928 (2003)
- Lin ML., "Suppression of PI3K", Akt signaling by synthetic bichalcone analog TSWU-CD4 induces ER stress-and Bax, Apoptosis, pp.2014, 19[DOI]
- Jung TW., "Metformin prevents endoplasmic reticulum stress-induced apoptosis through AMPK-PI3K-c-Jun NH2 pathway", Biochem Biophys Res Commun, 417, pp.147~152 (2012)
- Mounir Z., "Akt determines cell fate through inhibition of the PERK-eIF2αphosphorylation pathway", Sci Signal, 4, pp.ra62~ (2011)